
How Gen Z made Free From the flavor of modern wellness
Forget bland gluten-free loaves and chalky sugar-free chocolate. For Gen Z, Free From is culture, not compromise and it’s rewriting what health and indulgence look like
All stories

Forget bland gluten-free loaves and chalky sugar-free chocolate. For Gen Z, Free From is culture, not compromise and it’s rewriting what health and indulgence look like

Weight-loss drugs threaten to cut calorie consumption, but General Mills sees opportunity in a leaner consumer, betting big on protein, fiber and smarter supply chains

With GLP-1 users eating less often, chewy and long-lasting snacks like jerky, protein bites, gummies and gum are stepping up as the formats that make every portion count

Weight-loss drugs are billed as a $150bn threat to bakery and snacks, but so far the impact looks more hype than reality.

Mars’ $36 billion takeover of Kellanova has been given the green light from US antitrust regulators but Brussels pushes forward with antitrust investigation

Grupo Bimbo, PepsiCo, Kellanova, JM Smucker, Hershey, Ingredion and ADM are standing out in the food industry by proving that ethics and profitability go hand in hand

Snacks today are expected to provide more than just a moment of pleasure. They are working powerhouses, packed with functional ingredients that contribute to overall wellbeing

Ultra-processed foods (UPFs) face mounting scrutiny as regulators push for transparency. Will front-of-pack labelling drive real change or just add red tape?

GLP-1 drugs like Ozempic, Wegovy, and Mounjaro are reshaping the snack industry, slashing cravings and shrinking grocery sales. As impulsive snacking declines, brands must rethink their strategies or risk becoming obsolete

The term ‘GLP-1 friendly’ has quickly infiltrated the lexicon of the food and beverage industry, signalling a new wave of products tailored for individuals using new generation weight-loss medications like Ozempic, Wegovy, and Mounjaro. But does it have...